EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population‐Based Study

Unnur Gudnadottir iD, Ronny Wickström iD, Anna Gunnerbeck iD, Stefanie Prast-Nielsen iD, Nele Brusselaers iD

Clinical Pharmacology & Therapeutics · 2025-07 · 118 (1) · 206-217

DOI: 10.1002/cpt.3679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 15.04.2025. Verfasst von Unnur Gudnadottir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology (MTC), Karolinska Institutet, Solna, Sweden. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Epilepsy, Prenatal Exposure Delayed Effects, Histamine H2 Antagonists. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 10 million children in the world have epilepsy, with an unknown cause in half of the cases. The gut microbiome has been associated with various neurological disorders, and certain drugs greatly disturb the microbiome. Our aim was to study the association of prenatal and childhood exposure (before the age of two) to antibiotics, proton pump inhibitors (PPIs) and histamine‐2 receptor antagonists, and the risk of childhood epilepsy. Using population‐based registers, we included all live singleton births in Sweden from 2006 to 2017. Exposure was considered prescription(s) to antibiotics, proton pump inhibitors, or H2‐receptor antagonists (separately). Multivariable Cox regression was used to calculate hazard ratios and 95% confidence intervals. 708,903 mother–child dyads were included, and 0.5% of children had an epilepsy diagnosis. Average follow‐up was 3.8 years (IQR 1–6). Prenatal exposure to antibiotics (aHR 1.09, 95% CI 1.01–1.18) and PPIs (aHR 1.38, 95% CI 1.17–1.65) were associated with an increased risk of epilepsy. Exposure to antibiotics (1.11, 95% CI 1.02–1.21), PPIs (3.40, 95% CI 2.47–4.68) and H2RAs (1.65, 95% CI 1.03–2.64) before the age of two was associated with an increased risk of epilepsy after the age of two. Dose response analysis showed that one prescription of antibiotics in pregnancy or early life was not associated with an increased risk of epilepsy, while one prescription of PPIs in pregnancy or early life had an association. To conclude, our results support the hypothesis that microbiome modulating drugs are associated with an increased risk of epilepsy. This needs to be further validated in other studies, ideally including indications for drug use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsEpilepsyPrenatal Exposure Delayed EffectsHistamine H2 AntagonistsAnti-Bacterial AgentsHumansFemalePregnancySwedenMaleChild, PreschoolAdultInfantRisk FactorsChildRegistriesGastrointestinal MicrobiomeInfant, NewbornRisk Assessment

Substanzen

Proton Pump InhibitorsHistamine H2 AntagonistsAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology (MTC), Karolinska Institutet, Solna, Sweden.
  • Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Global Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Antwerp, Belgium.
  • Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.

ORCID-Profile: Unnur Gudnadottir, Ronny Wickström, Anna Gunnerbeck, Stefanie Prast-Nielsen, Nele Brusselaers

Zitieren

APA

Gudnadottir, U., Wickström, R., Gunnerbeck, A., Prast-Nielsen, S., & Brusselaers, N. (2025). Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population‐Based Study. Clinical Pharmacology & Therapeutics, 118(1), 206-217. https://doi.org/10.1002/cpt.3679

Vancouver

Gudnadottir U, Wickström R, Gunnerbeck A, Prast-Nielsen S, Brusselaers N. Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population‐Based Study. Clinical Pharmacology & Therapeutics. 2025;118(1):206-217. doi:10.1002/cpt.3679

BibTeX
@article{Gudnadottir2025,
  author = {Gudnadottir, Unnur and Wickström, Ronny and Gunnerbeck, Anna and Prast-Nielsen, Stefanie and Brusselaers, Nele},
  title = {Prenatal and Early Childhood Exposure to Antibiotics or Gastric Acid Inhibitors and Increased Risk of Epilepsy: A Nationwide Population‐Based Study},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  volume = {118},
  number = {1},
  pages = {206--217},
  doi = {10.1002/cpt.3679}
}
Kostenlos starten →